Concepedia

1689P Adverse event management during treatment with bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1: Treatment guidelines based on experience in clinical trials

James L. Gulley, Mario E. Lacouture, Alexander I. Spira, Helena Verdaguer Mata, Changhoon Yoo, Byoung Chul Cho, Christoph Helwig, Tasia Halady, C. Valencia, Marcis Bajars,

Annals of Oncology · 2021 · 12 citations · 0 references

Concepts

MedicineOncologyPharmacologyImmunotherapyMolecular OncologyPrecision MedicineCancer ImmunotherapyImmune-related Adverse Event ManagementTargeted Cancer TherapyTargeted TherapyAdverse Event Follow-up ManagementAdverse Event Risk ManagementPd-l1 BlockadeProgrammed Cell Death Protein 1 InhibitorsProgrammed Death-ligand 1 BiomarkerProgrammed Death-ligand 1 TargetingSerious Adverse Event ManagementTherapeutic Targeting Of Fusion Proteins